Can-Fite BioPharma Ltd.: common_shares_outstanding
| Value | {"unit": "shares", "value": 994394, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2024-12-31) |
| Status | current |
| Entity | Can-Fite BioPharma Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:35:01.962698+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5e32f722-e01b-42dd-bbac-19b33794f63a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-26-034447Retrieved: 2026-08-19T15:35:01.962698+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001536196/common-shares-outstanding/2024-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5e32f722-e01b-42dd-bbac-19b33794f63a
History
- supersedes {"unit": "shares", "value": 2983181793, "concept": "us-gaap:CommonStockSharesOutstanding"} (evidence 0001213900-25-031298)